GlaxoSmithKline
LON:GSK-GB
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2022
—
About
Pharmaceuticals: MajorFounded 1999
GlaxoSmithKline Plc is a global healthcare company which engages in developing, manufacturing, and marketing of pharmaceutical products including vaccines, over the counter medicines and health-related consumer products. It operates through the following segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare segment markets a range of consumer health products based on scientific innovation. The company was founded on December 6, 1999 and is headquartered in Brentford, the United Kingdom.
Headquarters
Executives
Name | Title | Gender |
Simon Dingemans | Chief Financial Officer & Executive Director | Male |
Philip Roy Hampton, MBA | Non-Executive Chairman | Male |
Dan Troy | Senior Vice President & General Counsel | Male |
Patrick J. T. Vallance, MD | Executive Director, President-R&D | Male |
Claire Thomas | Senior Vice President-Human Resources | Female |
Emma Walmsley | Chief Executive Officer & Executive Director | Female |
Ziba Shamsi | Head-Investor Relations | Female |
Mindful Investing Summary
GlaxoSmithKline - Competitors and Related Companies
How GlaxoSmithKline stacks up to its peers in thePharmaceuticals: Major industry or with competing business segments.
GlaxoSmithKline
LON:GSK-GB
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2022
—
AstraZeneca
LON:AZN-GB
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2022
—
Merck
NYS:MRK
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2022
—
Pfizer
NYS:PFE
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2022
—
Teva Pharmaceutical Industries
TAE:TEVA-IL
Pharmaceuticals: Generic
—
LARGE cap
(—)
—
since start of 2022
—
GW Pharmaceuticals
NAS:GWPH
Pharmaceuticals: Other
—
MID cap
(—)
—
since start of 2022
—